CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 44 enrolled
Drug / intervention
Magnetic Resonance Elastogram +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00543777
NCT00543777Phase 2Completed

Validation Study of Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease

M.D. Anderson Cancer Center·interventional·Posted Oct 15, 2007·Updated Apr 13, 2021

In Brief

A Phase 2 clinical trial evaluating Magnetic Resonance Elastogram and 2-Point Dixon Magnetic Resonance Imaging for Liver Cancer. Completed, enrolled 44 participants across 1 site.

Detailed Summary

The goal of this clinical research study is to test the accuracy of magnetic resonance elastogram (MRE) and 2-point dixon magnetic resonance imaging (2PD MRI) using new computer software (called "phase correction algorithm") in patients who might have liver disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Cancer
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 15, 2007
Enrollment StartSep 1, 2007
Primary CompletionJan 13, 2020
TodayJul 2, 2026
Enrollment to primary: 12.4 yearsPosted 18.7 years ago

Interventions

Magnetic Resonance Elastogramother

Pneumatic driver will be placed over the upper abdomen. Patient will feel a vibration (like a cell phone or beeper vibrating). This vibration will create very small waves in the body. The scanner will then receive the vibrations from the liver and use them to create images of the liver tissue.

2-Point Dixon Magnetic Resonance Imagingother

Imaging performed after the MRE procedure and lasting 20-60 seconds. This procedure is useful in identifying fat tissue.